Inflammasome activation and function in liver disease (original) (raw)

• Janeway, C. A., Jr Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).
  Article CAS PubMed Google Scholar
• Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994).
  Article CAS PubMed Google Scholar
• Shi, Y. Caught red-handed: uric acid is an agent of inflammation. J. Clin. Invest. 120, 1809–1811 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Seki, E. & Brenner, D. A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322–335 (2008).
  Article CAS PubMed Google Scholar
• Chassaing, B., Etienne-Mesmin, L. & Gewirtz, A. T. Microbiota-liver axis in hepatic disease. Hepatology 59, 328–339 (2014).
  Article CAS PubMed Google Scholar
• Schwabe, R. F., Seki, E. & Brenner, D. A. Toll-like receptor signaling in the liver. Gastroenterology 130, 1886–1900 (2006).
  Article CAS PubMed Google Scholar
• Gao, B. et al. Innate immunity in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G516–G525 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Szabo, G., Dolganiuc, A. & Mandrekar, P. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 44, 287–298 (2006).
  Article CAS PubMed Google Scholar
• Kubes, P. & Mehal, W. Z. Sterile inflammation in the liver. Gastroenterology 143, 1158–1172 (2012).
  Article CAS PubMed Google Scholar
• Chen, G. Y. & Nunez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826–837 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Warren, S. E. et al. Cutting edge: cytosolic bacterial DNA activates the inflammasome via Aim2. J. Immunol. 185, 818–821 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ogura, Y., Sutterwala, F. S. & Flavell, R. A. The inflammasome: first line of the immune response to cell stress. Cell 126, 659–662 (2006).
  Article CAS PubMed Google Scholar
• Szabo, G. & Csak, T. Inflammasomes in liver diseases. J. Hepatol. 57, 642–654 (2012).
  Article CAS PubMed Google Scholar
• Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417–426 (2002).
  Article CAS PubMed Google Scholar
• Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821–832 (2010).
  Article CAS PubMed Google Scholar
• Kumar, H., Kawai, T. & Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30, 16–34 (2011).
  Article CAS PubMed Google Scholar
• Mandrekar, P., Ambade, A., Lim, A., Szabo, G. & Catalano, D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54, 2185–2197 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Petrasek, J. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 122, 3476–3489 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Miura, K. et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice. Gastroenterology 139, 323–334 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228–232 (2006).
  Article CAS PubMed Google Scholar
• Rock, K. L., Kataoka, H. & Lai, J. J. Uric acid as a danger signal in gout and its comorbidities. Nat. Rev. Rheumatol. 9, 13–23 (2013).
  Article CAS PubMed Google Scholar
• Csak, T. et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54, 133–144 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Matsuzaka, T. et al. Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 56, 2199–2208 (2012).
  Article CAS PubMed Google Scholar
• Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408–415 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179–188 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Shulga, N. & Pastorino, J. G. Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure. J. Biol. Chem. 289, 26213–26225 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Petrasek, J., Dolganiuc, A., Csak, T., Kurt-Jones, E. A. & Szabo, G. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology 140, 697–708.e4 (2011).
  Article CAS PubMed Google Scholar
• Granowitz, E. V., Vannier, E., Poutsiaka, D. D. & Dinarello, C. A. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 79, 2364–2369 (1992).
  CAS PubMed Google Scholar
• Granowitz, E. V., Clark, B. D., Vannier, E., Callahan, M. V. & Dinarello, C. A. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 79, 2356–2363 (1992).
  CAS PubMed Google Scholar
• Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519–550 (2009).
  Article CAS PubMed Google Scholar
• Mehal, W. & Imaeda, A. Cell death and fibrogenesis. Semin. Liver Dis. 30, 226–231 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cosgrove, B. D. et al. An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-α. Hepatology 48, 276–288 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dinarello, C. A. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N. Engl. J. Med. 343, 732–734 (2000).
  Article CAS PubMed Google Scholar
• Gross, O., Thomas, C. J., Guarda, G. & Tschopp, J. The inflammasome: an integrated view. Immunol. Rev. 243, 136–151 (2011).
  Article CAS PubMed Google Scholar
• Davis, B. K., Wen, H. & Ting, J. P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707–735 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Guma, M. et al. Caspase 1-independent activation of interleukin-1β in neutrophil-predominant inflammation. Arthritis Rheum. 60, 3642–3650 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Joosten, L. A. et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1β. Arthritis Rheum. 60, 3651–3662 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Greten, F. R. et al. NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ. Cell 130, 918–931 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Mayer-Barber, K. D. et al. Caspase-1 independent IL-1β production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326–3330 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fantuzzi, G. et al. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. J. Immunol. 158, 1818–1824 (1997).
  CAS PubMed Google Scholar
• Coeshott, C. et al. Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl Acad. Sci. USA 96, 6261–6266 (1999).
  Article CAS PubMed Google Scholar
• Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246–1249 (2013).
  Article CAS PubMed Google Scholar
• Dinarello, C. A. Interleukin-18, a proinflammatory cytokine. Eur. Cytokine Netw. 11, 483–486 (2000).
  CAS PubMed Google Scholar
• Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179–185 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Imaeda, A. B. et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119, 305–314 (2009).
  CAS PubMed PubMed Central Google Scholar
• Serti, E. et al. Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication. Gastroenterology 147, 209–220 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Arshad, M. I., Piquet-Pellorce, C. & Samson, M. IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology. Liver Int. 32, 1200–1210 (2012).
  Article CAS PubMed Google Scholar
• Villarreal, D. O. & Weiner, D. B. Interleukin 33: a switch-hitting cytokine. Curr. Opin. Immunol. 28, 102–106 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Carriere, V. et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl Acad. Sci. USA 104, 282–287 (2007).
  Article CAS PubMed Google Scholar
• Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479–490 (2005).
  Article CAS PubMed Google Scholar
• Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl Acad. Sci. USA 106, 9021–9026 (2009).
  Article CAS PubMed Google Scholar
• Luzina, I. G. et al. Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J. Immunol. 189, 403–410 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Volarevic, V. et al. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J. Hepatol. 56, 26–33 (2012).
  Article CAS PubMed Google Scholar
• Marvie, P. et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J. Cell. Mol. Med. 14, 1726–1739 (2010).
  Article CAS PubMed Google Scholar
• Yin, H. et al. Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury. Biochem. Biophys. Res. Commun. 351, 940–946 (2006).
  Article CAS PubMed Google Scholar
• Amatucci, A. et al. Recombinant ST2 boosts hepatic Th2 response in vivo. J. Leukoc. Biol. 82, 124–132 (2007).
  Article CAS PubMed Google Scholar
• Oboki, K. et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl Acad. Sci. USA 107, 18581–18586 (2010).
  Article CAS PubMed Google Scholar
• Schroder, K., Zhou, R. & Tschopp, J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296–300 (2010).
  Article CAS PubMed Google Scholar
• Csak, T. et al. Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis. Liver Int. 34, 1402–1413 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Bauernfeind, F. G. et al. Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787–791 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).
  Article CAS PubMed Google Scholar
• Iyer, S. S. et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl Acad. Sci. USA 106, 20388–20393 (2009).
  Article CAS PubMed Google Scholar
• Latz, E. The inflammasomes: mechanisms of activation and function. Curr. Opin. Immunol. 22, 28–33 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ioannou, G. N. et al. Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH. J. Lipid Res. 56, 277–285 (2014).
  Article CAS PubMed Google Scholar
• Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857–865 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 (2011).
  Article CAS Google Scholar
• Kim, H. Y., Kim, S. J. & Lee, S. M. Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion. FEBS J. 282, 259–270 (2014).
  Article CAS PubMed Google Scholar
• Muruve, D. A. et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103–107 (2008).
  Article CAS Google Scholar
• Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222–230 (2011).
  Article CAS PubMed Google Scholar
• Rathinam, V. A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11, 395–402 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Poeck, H. et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 β production. Nat. Immunol. 11, 63–69 (2010).
  Article CAS PubMed Google Scholar
• Lozano-Ruiz, B. et al. Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis. J. Hepatol. 62, 64–71 (2015).
  Article CAS PubMed Google Scholar
• Grenier, J. M. et al. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS Lett. 530, 73–78 (2002).
  Article CAS PubMed Google Scholar
• Anand, P. K. et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 488, 389–393 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, G. Y., Liu, M., Wang, F., Bertin, J. & Nunez, G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186, 7187–7194 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745–757 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Normand, S. et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl Acad. Sci. USA 108, 9601–9606 (2011).
  Article CAS PubMed Google Scholar
• Chen, G. Y. Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis. Eur. J. Immunol. 44, 321–327 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Wlodarska, M. et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156, 1045–1059 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• O'Shea, R. S., Dasarathy, S., McCullough, A. J., Practice Guideline Committee of the American Association for the Study of Liver, D. & Practice Parameters Committee of the American College of, G. Alcoholic liver disease. Hepatology 51, 307–328 (2010).
  Article PubMed Google Scholar
• Mandrekar, P. & Szabo, G. Signalling pathways in alcohol-induced liver inflammation. J. Hepatol. 50, 1258–1266 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Peng, Y., French, B. A., Tillman, B., Morgan, T. R. & French, S. W. The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation. Exp. Mol. Pathol. 97, 305–313 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• McClain, C. J. et al. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci. 39, 1479–1485 (1986).
  Article CAS PubMed Google Scholar
• Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572–1585 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Xiao, J. et al. Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway. Int. J. Biol. Macromol. 69, 73–78 (2014).
  Article CAS PubMed Google Scholar
• Clemens, D. L. Use of cultured cells to study alcohol metabolism. Alcohol Res. Health 29, 291–295 (2006).
  PubMed PubMed Central Google Scholar
• Szabo, G. Gut–liver axis in alcoholic liver disease. Gastroenterology 148, 30–36 (2015).
  Article CAS PubMed Google Scholar
• Inokuchi, S. et al. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin. Exp. Res. 35, 1509–1518 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hoek, J. B., Cahill, A. & Pastorino, J. G. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 122, 2049–2063 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lieber, C. S., Jones, D. P., Losowsky, M. S. & Davidson, C. S. Interrelation of uric acid and ethanol metabolism in man. J. Clin. Invest. 41, 1863–1870 (1962).
  Article CAS PubMed PubMed Central Google Scholar
• Stiburkova, B., Pavlikova, M., Sokolova, J. & Kozich, V. Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration. PLoS ONE 9, e97646 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Petrasek J. et al. Metabolic danger signals, uric acid and ATP mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J. Leukoc. Biol. http://dx.doi.org/10.1189/jlb.3AB1214-590R.
• Kono, H. et al. Allopurinol prevents early alcohol-induced liver injury in rats. J. Pharmacol. Exp. Ther. 293, 296–303 (2000).
  CAS PubMed Google Scholar
• Ge, X. et al. High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J. Biol. Chem. 289, 22672–22691 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, M. et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26, 174–179 (2006).
  Article CAS PubMed Google Scholar
• Xu, J. et al. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death Differ. 21, 1229–1239 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Ganz, M. & Szabo, G. Immune and inflammatory pathways in NASH. Hepatol. Int. 7, 771–781 (2013).
  Article PubMed PubMed Central Google Scholar
• Mehal, W. Z. The inflammasome in liver injury and non-alcoholic fatty liver disease. Dig. Dis. 32, 507–515 (2014).
  Article PubMed Google Scholar
• Lamkanfi, M. & Kanneganti, T. D. The inflammasome: a remote control for metabolic syndrome. Cell Res. 22, 1095–1098 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J. & Paquot, N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105, 141–150 (2014).
  Article CAS PubMed Google Scholar
• Lee, H. M. et al. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62, 194–204 (2013).
  Article CAS PubMed Google Scholar
• Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat. Immunol. 11, 897–904 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ganz, M., Csak, T. & Szabo, G. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. World J. Gastroenterol. 20, 8525–8534 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Wree, A. et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59, 898–910 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Wree, A. et al. NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J. Mol. Med. (Berl.) 92, 1069–1082 (2014).
  Article CAS Google Scholar
• Mehal, W. Z. The Gordian Knot of dysbiosis, obesity and NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10, 637–644 (2013).
  Article PubMed Google Scholar
• Pan, J. J. & Fallon, M. B. Gender and racial differences in nonalcoholic fatty liver disease. World J. Hepatol. 6, 274–283 (2014).
  Article PubMed PubMed Central Google Scholar
• Csak, T. et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G433–G441 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Petrasek, J., Csak, T., Ganz, M. & Szabo, G. Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 28, 93–98 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Messina, J. P. et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61, 77–87 (2015).
  Article PubMed Google Scholar
• Saha, B. & Szabo, G. Innate immune cell networking in hepatitis C virus infection. J. Leukoc. Biol. 96, 757–766 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Heim, M. H. Innate immunity and HCV. J. Hepatol. 58, 564–574 (2013).
  Article CAS PubMed Google Scholar
• Dolganiuc, A. et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133, 1627–1636 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Chattergoon, M. A. et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog. 10, e1004082 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, W. et al. HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells. PLoS ONE 9, e84953 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Burdette, D. et al. Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex. J. Gen. Virol. 93, 235–246 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Jaeschke, H., Williams, C. D., Ramachandran, A. & Bajt, M. L. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int. 32, 8–20 (2012).
  Article CAS PubMed Google Scholar
• McGill, M. R. et al. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J. Clin. Invest. 122, 1574–1583 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• McGill, M. R. et al. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology 60, 1336–1345 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Williams, C. D., Koerner, M. R., Lampe, J. N., Farhood, A. & Jaeschke, H. Mouse strain-dependent caspase activation during acetaminophen hepatotoxicity does not result in apoptosis or modulation of inflammation. Toxicol. Appl. Pharmacol. 257, 449–458 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Jaeschke, H., Williams, C. D. & Farhood, A. No evidence for caspase-dependent apoptosis in acetaminophen hepatotoxicity. Hepatology 53, 718–719 (2011).
  Article PubMed Google Scholar
• Williams, C. D., Farhood, A. & Jaeschke, H. Role of caspase-1 and interleukin-1β in acetaminophen-induced hepatic inflammation and liver injury. Toxicol. Appl. Pharmacol. 247, 169–178 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Sander, L. E. & Blander, J. M. Inflammasome and toll-like receptor 9: Partners in crime in toxic liver injury. Hepatology 49, 2119–2121 (2009).
  Article CAS PubMed Google Scholar
• Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851–856 (2007).
  Article CAS PubMed Google Scholar
• Hoque, R. et al. P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G1171–G1179 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Williams, C. D. et al. Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury. Toxicol. Appl. Pharmacol. 252, 289–297 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kataoka, H., Kono, H., Patel, Z. & Rock, K. L. Evaluation of the contribution of multiple DAMPs and DAMP receptors in cell death-induced sterile inflammatory responses. PLoS ONE 9, e104741 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Kono, H., Chen, C. J., Ontiveros, F. & Rock, K. L. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J. Clin. Invest. 120, 1939–1949 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Antoniades, C. G. et al. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology 59, 1564–1576 (2014).
  Article CAS PubMed Google Scholar
• Abu-Amara, M. et al. Liver ischemia/reperfusion injury: processes in inflammatory networks—a review. Liver Transpl. 16, 1016–1032 (2010).
  Article PubMed Google Scholar
• Weigand, K. et al. Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg. 2012, 176723 (2012).
  Article PubMed PubMed Central Google Scholar
• Zhai, Y., Petrowsky, H., Hong, J. C., Busuttil, R. W. & Kupiec-Weglinski, J. W. Ischaemia–reperfusion injury in liver transplantation—from bench to bedside. Nat. Rev. Gastroenterol. Hepatol. 10, 79–89 (2013).
  Article CAS PubMed Google Scholar
• Jaeschke, H. Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts. J. Gastroenterol. Hepatol. 26, 173–179 (2011).
  Article CAS PubMed Google Scholar
• Gabrielli, M. et al. Steatotic livers. Can. we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Ann. Hepatol. 11, 891–898 (2012).
  Article PubMed Google Scholar
• Farrell, G. C., Teoh, N. C. & McCuskey, R. S. Hepatic microcirculation in fatty liver disease. Anat. Rec. (Hoboken) 291, 684–692 (2008).
  Article Google Scholar
• DuBray, B. J. Jr. et al. BH3-only proteins contribute to steatotic liver ischemia-reperfusion injury. J. Surg. Res. 194, 653–658 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Zhu, P. et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum. Gene Ther. 22, 853–864 (2011).
  Article CAS PubMed Google Scholar
• Huang, H. et al. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J. Immunol. 191, 2665–2679 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Kamo, N. et al. ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 58, 351–362 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Shimizu, S. et al. Involvement of ICE family proteases in apoptosis induced by reoxygenation of hypoxic hepatocytes. Am. J. Physiol. 271, G949–G958 (1996).
  CAS PubMed Google Scholar
• Shito, M. et al. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 63, 143–148 (1997).
  Article CAS PubMed Google Scholar
• Harada, H. et al. Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury. Transplantation 74, 1434–1441 (2002).
  Article CAS PubMed Google Scholar
• Takeuchi, D. et al. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology 39, 699–710 (2004).
  Article CAS PubMed Google Scholar
• Inoue, Y. et al. NLRP3 regulates neutrophil functions and contributes to hepatic ischemia-reperfusion injury independently of inflammasomes. J. Immunol. 192, 4342–4351 (2014).
  Article CAS PubMed Google Scholar
• Watanabe, A. et al. Inflammasome-mediated regulation of hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1248–G1257 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ouyang, X., Ghani, A. & Mehal, W. Z. Inflammasome biology in fibrogenesis. Biochim. Biophys. Acta 1832, 979–988 (2013).
  Article CAS PubMed Google Scholar
• Weiskirchen, R. & Tacke, F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg. Nutr. 3, 344–363 (2014).
  PubMed PubMed Central Google Scholar
• Seki, E. et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat. Med. 13, 1324–1332 (2007).
  Article CAS PubMed Google Scholar
• Khan, F., Peltekian, K. M. & Peterson, T. C. Effect of interferon-α, ribavirin, pentoxifylline, and interleukin-18 antibody on hepatitis C sera-stimulated hepatic stellate cell proliferation. J. Interferon Cytokine Res. 28, 643–651 (2008).
  Article CAS PubMed Google Scholar
• Gieling, R. G., Wallace, K. & Han, Y. P. Interleukin-1 participates in the progression from liver injury to fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1324–G1331 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• de Roos, B. et al. Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 9, 3244–3256 (2009).
  Article CAS PubMed Google Scholar
• Kamari, Y. et al. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J. Hepatol. 55, 1086–1094 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Isoda, K. et al. Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. J. Biol. Chem. 280, 7002–7009 (2005).
  Article CAS PubMed Google Scholar
• Dixon, L. J., Flask, C. A., Papouchado, B. G., Feldstein, A. E. & Nagy, L. E. Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS ONE 8, e56100 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Samstad, E. O. et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J. Immunol. 192, 2837–2845 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Wen, H., Ting, J. P. & O'Neill, L. A. A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation? Nat. Immunol. 13, 352–357 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ganz, M., Csak, T., Nath, B. & Szabo, G. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J. Gastroenterol. 17, 4772–4778 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10, 210–215 (2010).
  Article CAS PubMed Google Scholar
• Petrasek, J. et al. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc. Natl Acad. Sci. USA 110, 16544–16549 (2013).
  Article CAS PubMed Google Scholar
• Purohit, V. et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42, 349–361 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Neuman, M. G. et al. Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin. Exp. Res. 25, 251S–253S (2001).
  Article CAS PubMed Google Scholar
• Cohen, J. I., Roychowdhury, S., McMullen, M. R., Stavitsky, A. B. & Nagy, L. E. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139, 664–674 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Roychowdhury, S. et al. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology 49, 1326–1334 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sherlock, S. Liver disease in women. Alcohol, autoimmunity, and gallstones. West. J. Med. 149, 683–686 (1988).
  CAS PubMed PubMed Central Google Scholar
• Stranges, S. et al. Differential effects of alcohol drinking pattern on liver enzymes in men and women. Alcohol Clin. Exp. Res. 28, 949–956 (2004).
  Article CAS PubMed Google Scholar
• Hatton, J. et al. Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease. Addiction 104, 587–592 (2009).
  Article PubMed Google Scholar
• Askgaard, G. et al. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. J. Hepatol. 62, 1061–1067 (2015).
  Article PubMed Google Scholar
• Csak, T. et al. Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice. Hepatology 53, 1917–1931 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kohli, R. et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52, 934–944 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Day, C. P. & James, O. F. Steatohepatitis: a tale of two “hits”? Gastroenterology 114, 842–845 (1998).
  Article CAS PubMed Google Scholar
• Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836–1846 (2010).
  Article CAS PubMed Google Scholar
• Linton, S. D. et al. First-in-class pan caspase inhibitor developed for the treatment of liver disease. J. Med. Chem. 48, 6779–6782 (2005).
  Article CAS PubMed Google Scholar
• Shiffman, M. L. et al. Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor—a randomized placebo-controlled study in patients with chronic hepatitis, C. Aliment. Pharmacol. Ther. 31, 969–978 (2010).
  CAS PubMed Google Scholar
• Baskin-Bey, E. S. et al. Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am. J. Transplant 7, 218–225 (2007).
  Article CAS PubMed Google Scholar
• Pockros, P. J. et al. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis, C. Hepatology 46, 324–329 (2007).
  Article CAS PubMed Google Scholar
• MacKenzie, S. H., Schipper, J. L. & Clark, A. C. The potential for caspases in drug discovery. Curr. Opin. Drug Discov. Devel. 13, 568–576 (2010).
  CAS PubMed PubMed Central Google Scholar
• Church, L. D. & McDermott, M. F. Canakinumab, a fully-human mAb against IL-1β for the potential treatment of inflammatory disorders. Curr. Opin. Mol. Ther. 11, 81–89 (2009).
  CAS PubMed Google Scholar
• US National Library of Medicine. ClinicalTrials.gov [online], (2014).
• Mandrup-Poulsen, T., Pickersgill, L. & Donath, M. Y. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 6, 158–166 (2010).
  Article CAS PubMed Google Scholar
• Howard, C. et al. Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies. Cardiovasc. Diabetol. 13, 94 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Callus, B. A. & Vaux, D. L. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ. 14, 73–78 (2007).
  Article CAS PubMed Google Scholar
• Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 187, 61–70 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bhaskaracharya, A. et al. Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism. PLoS ONE 9, e93058 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, S. J. & Lim, Y. Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. Metabolism 63, 693–701 (2014).
  Article CAS PubMed Google Scholar
• Ambade, A., Catalano, D., Lim, A. & Mandrekar, P. Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice. Hepatology 55, 1585–1595 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117–121 (2011).
  Article CAS PubMed Google Scholar
• Broz, P. et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288–291 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Staun-Olsen, P., Bjorneboe, M., Prytz, H., Thomsen, A. C. & Orskov, F. Escherichia coli antibodies in alcoholic liver disease. Correlation to alcohol consumption, alcoholic hepatitis, and serum IgA. Scand. J. Gastroenterol. 18, 889–896 (1983).
  Article CAS PubMed Google Scholar
• Petrasek, J., Csak, T. & Szabo, G. Toll-like receptors in liver disease. Adv. Clin. Chem. 59, 155–201 (2013).
  Article CAS PubMed Google Scholar
• Bala, S., Marcos, M., Gattu, A., Catalano, D. & Szabo, G. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLoS ONE 9, e96864 (2014).
  Article PubMed PubMed Central Google Scholar
• Bode, C. et al. Antibiotics regulate the immune response in both presence and absence of lipopolysaccharide through modulation of Toll-like receptors, cytokine production and phagocytosis in vitro. Int. Immunopharmacol. 18, 27–34 (2014).
  Article CAS PubMed Google Scholar
• Li, P. et al. Mice deficient in IL-1 β-converting enzyme are defective in production of mature IL-1 β and resistant to endotoxic shock. Cell 80, 401–411 (1995).
  Article CAS PubMed Google Scholar
• Wang, S. et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501–509 (1998).
  Article CAS PubMed Google Scholar
• McGill, M. R. et al. Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers 19, 222–230 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Williams, C. D. et al. Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans. Toxicol. Appl. Pharmacol. 275, 122–133 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• McGill, M. R. et al. Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch. Toxicol. 88, 391–401 (2014).
  Article CAS PubMed Google Scholar